Cite
HARVARD Citation
Horgan, C. et al. (2019). Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience. Leukemia & lymphoma. 60 (12), pp. 3075-3077. [Online].